Unjha Formulations Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 4.48 Cr
as on 16-11-2024
- Company Age 30 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.20 M
as on 16-11-2024
- Revenue -8.13%
(FY 2023)
- Profit 11.90%
(FY 2023)
- Ebitda 34.67%
(FY 2023)
- Net Worth 13.01%
(FY 2023)
- Total Assets -1.29%
(FY 2023)
About Unjha Formulations
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 531762.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 4.48 Cr.
The company currently has active open charges totaling ₹3.20 M.
The Key Managerial Personnel (KMP) at Unjha Formulations Limited India are Jigar Ray as COMPANY SECRETARY and Ganpathbhai Prajapati as Cfo. Krutiben Patel, Hasmukh Darji, Jashodaben Patel, and Three other members serve as directors at the Company.
- CIN/LLPIN
L99999GJ1994PLC022932
- Company No.
022932
- Stock Symbol
BSE : 531762
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Sep 1994
- Date of AGM
16 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Patan, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Unjha Formulations?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krutiben Patel  | Managing Director | 01-Sep-2012 | Current |
| Jigar Ray | Company Secretary | 17-Feb-2020 | Current |
| Ganpathbhai Prajapati | CFO | 25-Sep-2015 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mustufa Jodhpurwala | Director | 06-Feb-2021 | Current |
| Hasmukh Darji | Director | 21-May-2001 | Current |
| Jashodaben Patel | Director | 31-Jan-2014 | Current |
| Esha Patel | Whole-Time Director | 10-May-2023 | Current |
| Jitendrakumar Limbachiya | Director | 08-Jan-2016 | Current |
Financial Performance of Unjha Formulations.
Unjha Formulations Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.13% decrease. The company also saw a substantial improvement in profitability, with a 11.9% increase in profit. The company's net worth Soared by an impressive increase of 13.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unjha Formulations?
In 2022, Unjha Formulations had a promoter holding of 36.92% and a public holding of 63.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Urvesh Psyllium Industries LimitedActive 29 years 8 monthsKrutiben Patel and Jashodaben Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dena Bank Creation Date: 01 Sep 2007 | ₹3.20 M | Open |
How Many Employees Work at Unjha Formulations?
Unjha Formulations has a workforce of 12 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unjha Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unjha Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
